Amithys Rahimian

580 total citations
10 papers, 379 citations indexed

About

Amithys Rahimian is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Amithys Rahimian has authored 10 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Amithys Rahimian's work include Glioma Diagnosis and Treatment (9 papers), Chromatin Remodeling and Cancer (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Amithys Rahimian is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Chromatin Remodeling and Cancer (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Amithys Rahimian collaborates with scholars based in France, Italy and United Kingdom. Amithys Rahimian's co-authors include Marc Sanson, Karima Mokhtari, Marianne Labussière, Anna Luisa Di Stefano, Khê Hoang‐Xuan, Stephanie Mangesius, Vincent Gleize, Ahmed Idbaïh, Richard S. Houlston and Marine Giry and has published in prestigious journals such as Annals of Neurology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Amithys Rahimian

10 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amithys Rahimian France 8 234 192 112 67 49 10 379
Vincent Gleize France 7 198 0.8× 218 1.1× 93 0.8× 54 0.8× 39 0.8× 8 385
Kay Ka-Wai Li China 8 239 1.0× 138 0.7× 82 0.7× 64 1.0× 33 0.7× 10 304
M Łysiak Sweden 10 150 0.6× 121 0.6× 82 0.7× 60 0.9× 26 0.5× 18 273
Olivier Saulnier France 6 168 0.7× 137 0.7× 83 0.7× 40 0.6× 34 0.7× 11 273
Lisa McFerrin United States 8 97 0.4× 275 1.4× 158 1.4× 56 0.8× 69 1.4× 9 462
Lorella Valletta Italy 8 251 1.1× 254 1.3× 99 0.9× 52 0.8× 48 1.0× 9 460
Nina Lelic United States 4 184 0.8× 184 1.0× 149 1.3× 46 0.7× 74 1.5× 5 347
Lorena Bissola Italy 6 244 1.0× 167 0.9× 123 1.1× 50 0.7× 51 1.0× 6 357
R E McLendon United States 8 130 0.6× 166 0.9× 52 0.5× 79 1.2× 84 1.7× 11 326
Cláudia C. Faria Portugal 13 175 0.7× 206 1.1× 81 0.7× 40 0.6× 60 1.2× 42 429

Countries citing papers authored by Amithys Rahimian

Since Specialization
Citations

This map shows the geographic impact of Amithys Rahimian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amithys Rahimian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amithys Rahimian more than expected).

Fields of papers citing papers by Amithys Rahimian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amithys Rahimian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amithys Rahimian. The network helps show where Amithys Rahimian may publish in the future.

Co-authorship network of co-authors of Amithys Rahimian

This figure shows the co-authorship network connecting the top 25 collaborators of Amithys Rahimian. A scholar is included among the top collaborators of Amithys Rahimian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amithys Rahimian. Amithys Rahimian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Labrèche, Karim, Ben Kinnersley, Giulia Berzero, et al.. (2018). Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci. Acta Neuropathologica. 135(5). 743–755. 38 indexed citations
2.
Labussière, Marianne, Claudia Prahst, Jaime Gállego Pérez‐Larraya, et al.. (2016). Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma. Cancer Investigation. 34(1). 39–44. 30 indexed citations
3.
Labussière, Marianne, Amithys Rahimian, Marine Giry, et al.. (2016). Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas. The Oncologist. 21(9). 1131–1135. 7 indexed citations
4.
Jacob, Sophie, Hassen Douzane, Philippe Lestaevel, et al.. (2015). EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. BMC Neurology. 15(1). 261–261. 16 indexed citations
5.
Kinnersley, Ben, Jonathan S. Mitchell, Konstantinos Gousias, et al.. (2015). Quantifying the heritability of glioma using genome-wide complex trait analysis. Scientific Reports. 5(1). 17267–17267. 23 indexed citations
6.
Rahimian, Amithys, Marine Giry, Andrea Sechi, et al.. (2015). TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas. Journal of Neuro-Oncology. 126(3). 441–446. 33 indexed citations
7.
Gleize, Vincent, Agustí Alentorn, Marianne Labussière, et al.. (2015). CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas. Annals of Neurology. 78(3). 355–374. 61 indexed citations
8.
Labussière, Marianne, Anna Luisa Di Stefano, Vincent Gleize, et al.. (2014). TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. British Journal of Cancer. 111(10). 2024–2032. 140 indexed citations
9.
Labussière, Marianne, Blandine Boisselier, Karima Mokhtari, et al.. (2014). O6.08 * COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA. Neuro-Oncology. 16(suppl 2). ii14–ii14. 1 indexed citations
10.
Stefano, Anna Luisa Di, Marianne Labussière, Giuseppe Lombardi, et al.. (2014). VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab. Journal of Neuro-Oncology. 121(3). 499–504. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Gleize Breakdown of academic impact, for papers by Kay Ka-Wai Li Breakdown of academic impact, for papers by M Łysiak Breakdown of academic impact, for papers by Olivier Saulnier Breakdown of academic impact, for papers by Lisa McFerrin Breakdown of academic impact, for papers by Lorella Valletta Breakdown of academic impact, for papers by Nina Lelic Breakdown of academic impact, for papers by Lorena Bissola Breakdown of academic impact, for papers by R E McLendon Breakdown of academic impact, for papers by Cláudia C. Faria
Rankless by CCL
2026